Therapeutic Lifestyle Changes and Drug Treatment for High Blood Cholesterol in China and Application of the Adult Treatment Panel III Guidelines
- 5 September 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (9) , 1260-1265
- https://doi.org/10.1016/j.amjcard.2005.06.068
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort StudyJAMA, 2004
- Estimates of global and regional potential health gains from reducing multiple major risk factorsThe Lancet, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Human blood pressure determination by sphygmomanometry.Circulation, 1993
- Enzymatic Determination of Total Serum CholesterolClinical Chemistry, 1974
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972